Koninklijke Philips (NYSE:PHG) Shares Gap Up to $20.06

Koninklijke Philips (NYSE:PHG) shares gapped up prior to trading on Monday . The stock had previously closed at $20.06, but opened at $20.66. Koninklijke Philips shares last traded at $20.69, with a volume of 104,334 shares.

Analyst Ratings Changes

Several research analysts have recently commented on the company. BNP Paribas lowered Koninklijke Philips from an “outperform” rating to an “underperform” rating in a research report on Wednesday, February 7th. StockNews.com upgraded Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a research report on Thursday, February 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $19.00.

Koninklijke Philips Stock Down 0.4 %

The firm has a market cap of $18.88 billion, a price-to-earnings ratio of -35.67, a price-to-earnings-growth ratio of 1.04 and a beta of 0.88. The company has a current ratio of 1.20, a quick ratio of 0.78 and a debt-to-equity ratio of 0.58. The stock has a 50-day moving average of $20.40 and a 200-day moving average of $20.86.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings data on Monday, January 29th. The technology company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.03. Koninklijke Philips had a positive return on equity of 14.17% and a negative net margin of 2.53%. The business had revenue of $5.45 billion during the quarter, compared to analyst estimates of $5.47 billion. As a group, sell-side analysts forecast that Koninklijke Philips will post 1.52 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Citigroup Inc. boosted its position in Koninklijke Philips by 1.3% during the 1st quarter. Citigroup Inc. now owns 36,882 shares of the technology company’s stock valued at $1,126,000 after purchasing an additional 483 shares during the period. Advisory Services Network LLC raised its stake in Koninklijke Philips by 28.7% during the 1st quarter. Advisory Services Network LLC now owns 2,226 shares of the technology company’s stock valued at $41,000 after acquiring an additional 496 shares in the last quarter. Capital Analysts LLC raised its stake in Koninklijke Philips by 6.3% during the 4th quarter. Capital Analysts LLC now owns 8,820 shares of the technology company’s stock valued at $206,000 after acquiring an additional 521 shares in the last quarter. Vident Advisory LLC raised its stake in Koninklijke Philips by 3.5% during the 4th quarter. Vident Advisory LLC now owns 17,290 shares of the technology company’s stock valued at $403,000 after acquiring an additional 581 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC raised its stake in Koninklijke Philips by 5.7% during the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 11,374 shares of the technology company’s stock valued at $265,000 after acquiring an additional 615 shares in the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.